Nissan Medical Industries Ltd (TLV:NISA)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
900.70
+1.40 (0.16%)
Sep 2, 2026, 5:24 PM IDT

Nissan Medical Industries Cash Flow Statement

Millions ILS. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
7.274.177.915.65-36.0536.01
Depreciation & Amortization
26.0727.829.6431.1428.6525.6
Loss (Gain) From Sale of Assets
-0.03--0.2-0.040.07
Asset Writedown & Restructuring Costs
----23.79-
Loss (Gain) From Sale of Investments
-0.01-0.13-0.01-0.010.05-5.39
Loss (Gain) on Equity Investments
0.27-0.18-1.37.060.64-4.62
Stock-Based Compensation
0.280.471.180.580.271.45
Other Operating Activities
20.1915.1717.0734.083.6125.89
Change in Accounts Receivable
12.28-8.4820.6133.8-19.71-16.45
Change in Inventory
2.4442.41-54.41-6.078.41-52
Change in Accounts Payable
0.79-19.047.08-7.415.2912.21
Change in Other Net Operating Assets
-5.980.45-0.946.69-3.22-4.8
Operating Cash Flow
63.5462.6426.83105.7211.6717.98
Operating Cash Flow Growth
56.11%133.44%-74.62%805.56%-35.07%-85.33%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-31.95-26.11-6.09-9.82-9.18-8.16
Sale of Property, Plant & Equipment
0.030.060.030.260.170.03
Sale (Purchase) of Intangibles
-0.03-0.02-0.21-0.36-0.51-0.14
Investment in Securities
2.41.713.79--0.158.42
Other Investing Activities
4.3510.66-11.39--5.48
Investing Cash Flow
-25.2-13.71-3.87-9.93-9.685.62

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-10.2523.927.3213.37-
Long-Term Debt Issued
-55.7249.11-42.7189.91
Total Debt Issued
59.5565.9773.037.3256.0889.91
Short-Term Debt Repaid
---0.5---3.42
Long-Term Debt Repaid
--81.84-74.91-73.67-66.82-80.87
Lease Payments
-5.25-5.83-9.18-6.32-4.14-3.92
Total Debt Repaid
-74.68-81.84-75.41-73.67-66.82-84.29
Net Debt Issued (Repaid)
-15.13-15.87-2.38-66.35-10.755.61
Common Dividends Paid
-16.53-16.53-6.81--4-9.08
Other Financing Activities
-10.7-12.32-23.18-24.36-11.04-27.73
Financing Cash Flow
-42.37-44.72-32.37-90.71-25.78-31.2

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-1.82-2.230.260.463.03-0.88
Net Cash Flow
-5.841.99-9.145.53-20.75-8.48

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
31.636.5320.7495.92.499.82
Free Cash Flow Growth
25.42%76.09%-78.37%3745.07%-74.60%-90.97%
Free Cash Flow After Leases
26.3530.6911.5789.57-1.655.9
Free Cash Flow After Leases Growth
59.90%165.33%-87.09%---94.40%
Free Cash Flow Margin
5.20%5.60%3.12%13.07%0.36%1.47%
Free Cash Flow Per Share
3.314.022.2810.560.281.08
Levered Free Cash Flow
34.0345.745.8954.04-4.51-1.37
Unlevered Free Cash Flow
38.5753.2414.2367.331.753.18

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
12.3212.3213.7916.3111.0410.11
Cash Income Tax Paid
2.992.996.299.32.3411.64
Change in Working Capital
9.5215.33-27.6527.02-9.24-61.03